Barclays’s Cardinal Health CAH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-1,200
| Closed | -$64K | – | 4723 |
|
|
2020
Q4 | $64K | Hold |
1,200
| – | – | ﹤0.01% | 4313 |
|
|
2020
Q3 | $56K | Hold |
1,200
| – | – | ﹤0.01% | 4538 |
|
|
2020
Q2 | $63K | Sell |
1,200
-108,500
| -99% | -$5.59M | ﹤0.01% | 4815 |
|
|
2020
Q1 | $5.26M | Sell |
109,700
-5,900
| -5% | -$306K | ﹤0.01% | 1421 |
|
|
2019
Q4 | $5.85M | Buy |
115,600
+30,100
| +35% | +$1.55M | ﹤0.01% | 1847 |
|
|
2019
Q3 | $4.04M | Sell |
85,500
-2,600
| -3% | -$119K | ﹤0.01% | 2041 |
|
|
2019
Q2 | $4.15M | Buy |
88,100
+55,800
| +173% | +$2.57M | ﹤0.01% | 2046 |
|
|
2019
Q1 | $1.55M | Sell |
32,300
-20,700
| -39% | -$1.04M | ﹤0.01% | 2878 |
|
|
2018
Q4 | $2.36M | Sell |
53,000
-10,900
| -17% | -$568K | ﹤0.01% | 2239 |
|
|
2018
Q3 | $3.45M | Buy |
63,900
+5,900
| +10% | +$302K | ﹤0.01% | 2226 |
|
|
2018
Q2 | $2.83M | Sell |
58,000
-32,900
| -36% | -$1.87M | ﹤0.01% | 2238 |
|
|
2018
Q1 | $5.7M | Buy |
90,900
+17,700
| +24% | +$1.21M | ﹤0.01% | 1544 |
|
|
2017
Q4 | $4.49M | Buy |
73,200
+49,300
| +206% | +$3.05M | ﹤0.01% | 1746 |
|
|
2017
Q3 | $1.6M | Sell |
23,900
-19,800
| -45% | -$1.4M | ﹤0.01% | 2557 |
|
|
2017
Q2 | $3.4M | Buy |
43,700
+25,500
| +140% | +$1.92M | ﹤0.01% | 1778 |
|
|
2017
Q1 | $1.48M | Sell |
18,200
-5,100
| -22% | -$401K | ﹤0.01% | 2363 |
|
|
2016
Q4 | $1.68M | Sell |
23,300
-27,600
| -54% | -$2M | ﹤0.01% | 2271 |
|
|
2016
Q3 | $3.96M | Buy |
50,900
+11,200
| +28% | +$905K | ﹤0.01% | 1474 |
|
|
2016
Q2 | $3.1M | Buy |
39,700
+26,800
| +208% | +$2.14M | ﹤0.01% | 1661 |
|
|
2016
Q1 | $1.04M | Sell |
12,900
-18,300
| -59% | -$1.49M | ﹤0.01% | 2475 |
|
|
2015
Q4 | $2.78M | Buy |
31,200
+6,100
| +24% | +$518K | ﹤0.01% | 1758 |
|
|
2015
Q3 | $1.91M | Buy |
25,100
+7,500
| +43% | +$627K | ﹤0.01% | 2168 |
|
|
2015
Q2 | $1.46M | Buy |
17,600
+4,700
| +36% | +$415K | ﹤0.01% | 2516 |
|
|
2015
Q1 | $1.16M | Sell |
12,900
-3,600
| -22% | -$310K | ﹤0.01% | 2833 |
|
|
2014
Q4 | $1.32M | Buy |
16,500
+2,800
| +20% | +$221K | ﹤0.01% | 2929 |
|
|
2014
Q3 | $1.01M | Sell |
13,700
-800
| -6% | -$58.2K | ﹤0.01% | 3338 |
|
|
2014
Q2 | $986K | Sell |
14,500
-4,400
| -23% | -$300K | ﹤0.01% | 3350 |
|
|
2014
Q1 | $1.3M | Sell |
18,900
-121,300
| -87% | -$8.44M | ﹤0.01% | 2948 |
|
|
2013
Q4 | $9.25M | Buy |
140,200
+73,700
| +111% | +$4.5M | 0.01% | 1313 |
|
|
2013
Q3 | $3.46M | Sell |
66,500
-98,300
| -60% | -$4.99M | ﹤0.01% | 2021 |
|
|
2013
Q2 | $7.78M | Buy |
+164,800
| New | +$7.53M | 0.01% | 1279 |
|
Other funds holding CAH
VCM
VPM
Barclays's CAH Position: Q1 2026 in Review
Barclays reduced its Cardinal Health (CAH) stake by 18% in Q1 2026, selling an estimated $46.2M and leaving 993,914 shares worth $210M. The position accounts for 0.05% of the portfolio, ranked #288.
Barclays first reported a position in CAH in Q2 2013 and has held it in 52 quarters since. The position peaked at $249M in Q3 2025. 1,423 funds tracked by Wall St. Rank hold CAH as of Q1 2026.
- Barclays held 993,914 shares of Cardinal Health worth $210M as of Q1 2026.
- Barclays sold 214,685 Cardinal Health shares in Q1 2026, an estimated $46.2M.
- Cardinal Health made up 0.05% of Barclays's portfolio in Q1 2026, its #288 holding.
- Barclays first reported a position in Cardinal Health in Q2 2013 and has held it in 52 quarters since.
- Barclays's Cardinal Health position peaked at $249M in Q3 2025.
- 1,423 funds tracked by Wall St. Rank held Cardinal Health as of Q1 2026.
Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.